Aprepitant and Ipf - a phase IV clinical study of FDA data

Summary:

Ipf is reported as a side effect among people who take Aprepitant (aprepitant), especially for people who are female, 40-49 old, have been taking the drug for < 1 month also take Cetirizine Hydrochloride, and have Rheumatoid arthritis.

The phase IV clinical study analyzes which people have Ipf when taking Aprepitant. It is created by eHealthMe based on reports of 6,989 people who have side effects when taking Aprepitant from the FDA, and is updated regularly.

What is Aprepitant?

Aprepitant has active ingredients of aprepitant. eHealthMe is studying from 6,992 Aprepitant users. Check the latest studies of Aprepitant.

What is Ipf?

Ipf is found to be associated with 2,155 drugs and 2,248 conditions by eHealthMe. Check the latest studies of Ipf.

On Oct, 24, 2025

6,989 people reported to have side effects when taking Aprepitant.
Among them, 65 people (0.93%) have Ipf.

Among these 65 people:

How long have people been on Aprepitant when they have Ipf? *

What is the gender of people who have Ipf when taking Aprepitant? *

female: 96.15 %
male: 3.85 %

What is the age of people who have Ipf when taking Aprepitant? *

What are other drugs people take besides Aprepitant? *

Acetaminophen: 52 people, 80.00%
Cetirizine Hydrochloride: 52 people, 80.00%
Remicade: 51 people, 78.46%
Simponi: 51 people, 78.46%
Sulfasalazine: 50 people, 76.92%
Prednisone: 50 people, 76.92%
Diclofenac Potassium: 49 people, 75.38%
Stelara: 49 people, 75.38%
Folic Acid: 48 people, 73.85%
Enbrel: 48 people, 73.85%

What are other side effects people have besides Ipf? *

Pneumonia: 53 people, 81.54%
Dizziness: 46 people, 70.77%
Nausea And Vomiting: 41 people, 63.08%
Sleep Disorder: 41 people, 63.08%
Confusional State: 40 people, 61.54%
Nausea (feeling of having an urge to vomit): 40 people, 61.54%
Wheezing (a high-pitched whistling sound made while you breath): 39 people, 60.00%
Memory Loss: 39 people, 60.00%
Oedema (fluid collection in tissue): 38 people, 58.46%
Joint Range Of Motion Decreased (disease of joint movement): 38 people, 58.46%

What are the existing conditions these people have? *

Rheumatoid Arthritis (a chronic progressive disease causing inflammation in the joints): 52 people, 80.00%
Psoriatic Arthropathy (inflammation of the skin and joints with kin condition which typically causes patches (plaques) of red, scaly skin to develop): 44 people, 67.69%
Arthritis (form of joint disorder that involves inflammation of one or more joints): 21 people, 32.31%
Systemic Lupus Erythematosus (an autoimmune disease, which means the body's immune system mistakenly, attacks healthy tissue): 19 people, 29.23%
Stress And Anxiety: 19 people, 29.23%
Psoriasis (immune-mediated disease that affects the skin): 13 people, 20.00%
Headache (pain in head): 11 people, 16.92%
Sinusitis (inflammation of sinus): 10 people, 15.38%
Indigestion: 9 people, 13.85%
Fever: 9 people, 13.85%

* Approximation only. Some reports may have incomplete information.

Do you take Aprepitant and have Ipf?

- Check whether Ipf is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Aprepitant:

Aprepitant (6,992 reports)

Ipf treatments and more:

Ipf (79,192 reports)

Browse all side effects of Aprepitant:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Ipf:

Ipf (2,155 drugs)

Browse all the conditions that are associated with Ipf:

Ipf (2,248 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on aprepitant (the active ingredients of Aprepitant) and Aprepitant (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.